AM
Aal Mahalaxmi
About Aal Mahalaxmi
Data last updated:
Aal Mahalaxmi is a Director at Niradhi Oncology Private Limited (since 2022). The companies operate in Non-Profit Organizations. Niradhi Oncology Private Limited reported revenue of ₹3.6 Lakh (FY 2024). Earlier, Aal Mahalaxmi was a Director at P.S Study Smart Private Limited (from 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Apr 2022 | 2022 | ₹3.6 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Jun 2020 | 2020 | ₹24.6 Lakh (FY 2023) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aal Mahalaxmi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vijay Bhaskar Lakshman | 09391301 | Niradhi Oncology Private Limited | Director |
| Yellakyathanahalli Padmaprabhaiah Pramod | 09574725 | Niradhi Oncology Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aal Mahalaxmi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aal Mahalaxmi
Aal Mahalaxmi currently holds 1 directorship: Niradhi Oncology Private Limited (Director, since 18 Apr 2022, revenue ₹3.6 Lakh (FY 2024)).
Aal Mahalaxmi was first appointed on 17 Jun 2020 as Director at P.S Study Smart Private Limited. The most recent appointment on record is 18 Apr 2022 at Niradhi Oncology Private Limited.
Aal Mahalaxmi held 1 earlier board appointment: P.S Study Smart Private Limited (Director, from 17 Jun 2020).
The current boards of Aal Mahalaxmi's companies include Vijay Bhaskar Lakshman (Niradhi Oncology Private Limited), Yellakyathanahalli Padmaprabhaiah Pramod (Niradhi Oncology Private Limited).